Cargando…
Pharmacological inhibition of STAT3 by BP‐1‐102 inhibits intracranial aneurysm formation and rupture in mice through modulating inflammatory response
As an inhibitor of STAT3, BP‐1‐102 can regulate the inflammation response caused by vascular smooth muscle cells (VSMCs) by inhibiting the JAK/STAT3/NF‐κB pathway, thereby attenuating the symptoms of intracranial aneurysm (IA). IA mouse model was established by stereotactic injection of elastase to...
Autores principales: | Jiang, Zhixian, Huang, Jiaxin, You, Lingtong, Zhang, Jinning, Li, Bingyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817916/ https://www.ncbi.nlm.nih.gov/pubmed/33474811 http://dx.doi.org/10.1002/prp2.704 |
Ejemplares similares
-
Multiple overlapping stent-assisted coiling improves efficacy and safety of treatment for complex intracranial aneurysms: a randomized trial
por: You, Lingtong, et al.
Publicado: (2021) -
Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition
por: Oleksak, Patrik, et al.
Publicado: (2021) -
Ruptured Intracranial Aneurysms
por: McCaughey, W. T. E.
Publicado: (1956) -
Modified murine intracranial aneurysm model: aneurysm formation and rupture by elastase and hypertension
por: Hosaka, Koji, et al.
Publicado: (2014) -
Endovascular coil embolization of aneurysm neck for the treatment of ruptured intracranial aneurysm with bleb formation
por: Wan, Jun, et al.
Publicado: (2014)